Pharmacological treatments in MS
About the resource
The fact that pharmacological options now exist for some people with MS means they need to be increasingly more informed and updated about their disease, its daily management and about progress in research. This has resulted in an evolution in the relationship between the clinician, the MS nurse and the “patient”. Today, more than ever, a person with MS has the tools to be an active decision-maker when it comes to choosing a treatment.
Whether you are a healthcare professional, a person with MS or a family member, we hope that this issue of MS in focus answers your questions about MS pharmacological treatments.
Inside:
- Introduction to pharmacological treatments in MS
- Immunomodulating therapy of MS
- Immunosuppressant drugs in MS
- Pharmacological treatments for MS symptoms
- Treating an exacerbation
- Safety in clinical trials of new pharmacological treatments
- Access to treatment worldwide
- Choosing medication – two views
Published: 2011
Not found the language you were looking for?
Help us translate it into other languages
We're always looking for member organisations to repurpose and translate MSIF's resources into other languages. Not a member? If we don't have a member that speaks your language and you would like to translate our resources, we'd love to hear from you to discuss options and explore what's possible!
Get in touchTranslate it for personal use
Alternatively, if you wanted to translate the PDF for personal use, you can use Google’s Translate tool. As Google Translate is an automated translation service, you should not rely on it being absolutely accurate.
Read this PDF in another language, using Google TranslateContact us
If you have any questions or feedback on our resource, please contact us on our website.
Contact usGlobal information statement – EBV and MS
Genes and MS 101
Myelin 101
Preview
